Key Principles and Recommended Regimens for First-line Antiretroviral Therapy

  • Author: Paul E. Sax, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 10/5/18 (What's New)

Summary

  • Recent investigations have studied newer agents as part of NRTI-sparing regimens in treatment-naive patients
  • The IAS-USA guidelines mention 2 options, pending further data on other strategies, for the rare situation in which a patient cannot receive abacavir, tenofovir AF, or tenofovir DF[IAS-USA ART]:

Action required